Article Text

Download PDFPDF

Observational series on women using the contraceptive Mirena® concurrently with anti-epileptic and other enzyme-inducing drugs
  1. Walli Bounds, SCM, Principal Research Fellow1 and
  2. John Guillebaud, FRCSE, FRCOG, Professor of Family Planning and Reproductive Health2
  1. Department of Obstetrics and Gynaecology, University College London and Research Co-ordinator, Margaret Pyke Centre*, London, UK
  2. Department of Obstetrics and Gynaecology, University College London and Medical Director, Margaret Pyke Centre, London, UK
  1. Correspondence Mrs Walli Bounds, 12 Balmoral Close, Westleigh Avenue, Putney, London SW15 6RP, UK


Context Contraception for women on enzyme-inducing drugs.

Objective To gather preliminary information on the contraceptive efficacy of the hormone-releasing intrauterine system (IUS) Mirena®, when used concurrently with enzyme-inducers.

Design Observational series.

Setting/participants Mirena® users on enzyme-inducers were recruited from within the Margaret Pyke Centre and via doctors from throughout the UK. Data were collected systematically on structured questionnaires with particular reference to duration of Mirena® use, exposure to pregnancy risk, type of concurrent medication, and reasons for drop-out.

Main outcome measure Accidental pregnancies.

Results To date, 56 women have provided follow-up information. Most took enzyme-inducers for epilepsy. They have accumulated 1454 months of use, of which 1075 months represent exposure to pregnancy risk. Only one apparently true Mirena® failure has been documented, representing a failure rate of 1.1 per 100 woman-years (95% CI 0.03-6.25). Including a second pregnancy, probably conceived after the Mirena® had been removed, would raise the failure rate to 2.2 per 100 woman-years (95% CI 0.27-8.07). Although 9/30 Mirena® removals were followed by re-insertion, only the first segment of use is analysed.

Conclusion As this is a pilot study, no firm conclusions can be drawn, but our preliminary results suggest that any increased pregnancy risk, if it exists, falls within acceptable bounds.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * Now retired